F. Gudiol
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Nosocomial Infections in ICU 6
- Co-authors
- Javier ArizaRomán PallarésJordi CarratalàMiquel PujolG Rufı́P. F. ViladrichA. Fernández‐SevillaA. Foz
- Journals
- Clinical Infectious Diseases (9 papers)Antimicrobial Agents and Chemotherapy (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (4 papers)Clinical Microbiology and Infection (3 papers)Microbial Drug Resistance (2 papers)
- Partner nations
- SpainUnited StatesAustralia
In The Last Decade
F. Gudiol
45 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 489
- Applied Microbiology and Biotechnology 185
- Small Animals 611
- Endocrinology 251
- Clinical Biochemistry 262
Countries citing papers authored by F. Gudiol
This map shows the geographic impact of F. Gudiol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gudiol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gudiol more than expected).
Fields of papers citing papers by F. Gudiol
This network shows the impact of papers produced by F. Gudiol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gudiol. The network helps show where F. Gudiol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Gudiol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 25 | |
| 2 | 2012 | 21 | |
| 3 | 2011 | 77 | |
| 4 | 2009 | 138 | |
| 5 | 2008 | 37 | |
| 6 | 2007 | 44 | |
| 7 | 2005 | 94 | |
| 8 | 2004 | 17 | |
| 9 | 2003 | 5 | |
| 10 | 2002 | 41 | |
| 11 | 2001 | 4 | |
| 12 | 2000 | 104 | |
| 13 | 1998 | 35 | |
| 14 | 1997 | 35 | |
| 15 | 1996 | 137 | |
| 16 | 1995 | 141 | |
| 17 | 1995 | 138 | |
| 18 | 1994 | 46 | |
| 19 | 1993 | 65 | |
| 20 | [Acute pneumonia of extra-hospital ogigin. Etiologic distribution in 415 cases]. | 1978 | 2 |
About F. Gudiol
F. Gudiol is a scholar working on Molecular Medicine, Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Microbiology and Small Animals, having authored 45 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (15 papers), Antibiotic Resistance in Bacteria (8 papers), Brucella: diagnosis, epidemiology, treatment (7 papers), Nosocomial Infections in ICU (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Bacterial Infections and Vaccines (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Molecular Medicine (489 citations), Applied Microbiology and Biotechnology (185 citations), Small Animals (611 citations), Endocrinology (251 citations) and Clinical Biochemistry (262 citations). F. Gudiol has collaborated with scholars based in Spain, United States and Australia. Frequent co-authors include Javier Ariza, Román Pallarés, Jordi Carratalà, Miquel Pujol, G Rufı́, P. F. Viladrich, A. Fernández‐Sevilla, A. Foz, T. Pellicer and Jordi Dorca. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Microbiology and Infection and Microbial Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.